Bambusa Therapeutics (NASDAQ:BBTX) Director Ra Capital Management, L.P. Buys 453,820 Shares of Stock

Key Points

  • RA Capital Management purchased 453,820 Bambusa Therapeutics shares on October 30 at an average price of $14.63, for about $6.64 million.
  • RA Capital also bought 2.5 million shares on November 2 at $16 each, a $40 million transaction. Bambusa shares opened at $16 on Wednesday and have traded between $13.60 and $17.42 over the past 52 weeks.

Bambusa Therapeutics, Inc. (NASDAQ:BBTX - Get Free Report) Director Ra Capital Management, L.P. purchased 453,820 shares of the business's stock in a transaction dated Friday, October 30th. The shares were purchased at an average price of $14.63 per share, for a total transaction of $6,639,386.60. Following the acquisition, the director directly owned 453,820 shares of the company's stock, valued at $6,639,386.60. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Ra Capital Management, L.P. also recently made the following trade(s):

  • On Monday, November 2nd, Ra Capital Management, L.P. purchased 2,500,000 shares of Bambusa Therapeutics stock. The stock was purchased at an average price of $16.00 per share, with a total value of $40,000,000.00.

Bambusa Therapeutics Stock Performance

Shares of NASDAQ:BBTX opened at $16.00 on Wednesday. Bambusa Therapeutics, Inc. has a 52 week low of $13.60 and a 52 week high of $17.42.

See Also

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Bambusa Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Bambusa Therapeutics and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles